Neuromodulation devices from companies including Medtronic (NYSE:MDT), Abbott (NYSE:ABT) and SPR Therapeutics are showing promise treating pain. That’s one of the initial takeaways from study results that medical device companies in the neuromodulation space are touting this weekend at NANS 2020 in Las Vegas. NANS is a joint conference of Congress of Neurological Surgeons and the […]
Abbott Q4 sales beat The Street
Abbott (NYSE:ABT) shares are up this morning on reported fourth-quarter 2019 earnings that met Wall Street analysts’ expectations, with sales beating The Street. The Abbott Park, Ill. company posted profits of $1.705 billion or $0.95 per share, on sales of $8.31 billion for the three months ended Dec. 31, 2019, for a bottom-line gain of […]
Abbott wins MitraClip patent spat with Edwards — for now
The U.S. Patent Trial and Review Board (PTAB) this week shot down an attempt by Edwards Lifesciences (NYSE:EW) to invalidate the patents that Abbott (NYSE:ABT) holds on its MitraClip transcatheter mitral valve repair (TMVR) device. In a ruling published Thursday, the PTAB said Edwards failed to show that it would prevail in with at least one […]
FDA-approved clinical trial to study expanded use of Abbott’s MitraClip
Abbott (NYSE:ABT) said today that U.S. FDA has approved a clinical trial to study the effectiveness of its MitraClip transcatheter mitral valve repair device in people eligible for open-heart surgery. The MitraClip has been available in the U.S. since 2013 and Europe since 2008 — but is only indicated as an option for people who don’t have […]
Abbott boosts support for Bigfoot Biomedical and its diabetes treatment tech
Diabetes treatment tech company Bigfoot Biomedical has raised another $45 million in the initial tranche of a Series C equity financing, with collaborator Abbott (NYSE:ABT) as the lead investor. “We are excited to announce Abbott’s deepening support of Bigfoot Biomedical with this Series C financing,” Bigfoot Biomedical CEO Jeffrey Brewer said in a news release today. […]
Miles White’s fearless strategy for growing Abbott
With strong leadership and a taste for risk-taking, outgoing CEO Miles White left no stone unturned as he grew Abbott into one of the world’s largest medical device companies. Few medical device companies have seen the growth and transformation that Abbott (NYSE:ABT) has seen under the leadership of Miles White. During his two decades as […]
Funck to move up to CFO spot at Abbott
As Abbott (NYSE:ABT) plans a change at the corner office for the first time in decades, the company is getting a new CFO, too. Abbott’s board yesterday appointed Robert Funck Jr. as the company’s new EVP and CFO, effective March 1, according to an SEC filing. Funck will replace Brian Yoor, who will officially retire on […]
Abbott LVAD wins FDA approval for implantation without open heart surgery
Abbott (NYSE:ABT) today announced that FDA has approved implantation of its HeartMate 3 LVAD via lateral thoracotomy — a less invasive approach than open-heart surgery. The approval comes about a year and a half after Medtronic (NYSE:MDT) won a similar approval for the competing HeartWare HVAD pump. Lateral thoracotomy involves a surgeon making an incision between a person’s […]
The 10 greatest medtech advances of the 2010s
From disposable endoscopes to TAVR to robotic surgery, there’s a whole host of medtech advances widely available now that weren’t around much 10 years ago. “In terms of technological advances, I would put this past decade as one of the most important for medical technology. From connected devices and robotics, to advances in material sciences […]
10 medical device industry stories you need to know
From leadership changes to tax repeal to robots — lots of robots — this was a busy year for the medical device industry. Here are 10 stories in the medtech space that especially caught the eye of MassDevice and Medical Design & Outsourcing editors and readers in 2019. Next>>
Abbott issues field safety notice for Heartmate 3 LVAS power unit
Abbott (NYSE:ABT) has issued a field safety notice for its HeartMate 3 Left Ventricular Assist System mobile power unit, citing loss of power due to static electricity. The notice identifies power loss to the HeartMate Mobile Power Unit Module due to static electricity. The power unit is connected to the HeartMate 3 Left Ventricular Assist System […]
- 1
- 2
- 3
- …
- 71
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube